1-5 of 5
Christopher Arthur, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Upfront Imatinib with Selective Early Switching to Nilotinib Leads to Excellent Achievement of Deep Molecular Response in Chronic Phase CML: 5 Year (Final) Analysis of the TIDEL-II Study

David T. Yeung, BSc, MBBS, FRACP, FRCPA, Michael Philip Osborn, MBBS, Deborah L White, PhD FFSc (RCPA), Susan Branford, PhD, Tracey Gerber, Belinda Butcher, BSc MBiostat PhDCMPP, Samar Issa, MBBS FRACP FRCPA, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD, Mark S Hertzberg, MBBS PhDFRACP FRCPA, David Gottlieb, MBBS MDFRACP FRCPA, Anthony P Schwarer, MD MBBS (Hons), FRACP, FRCPA, Robin Filshie, PhDFRACP FRCPA, Christopher Arthur, MD, Yiu-Lam Kwan, MBBS, FRACP, FRCPA, Cecily Forsyth, MBBS, FRACP, FRCPA, John Taper, MBBS FRACP FRCPA, David M. Ross, MBBS, PhD FRACP, FRCPA, Constantine S. Tam, MBBS, Anthony K. Mills, MBBS, FRACP, FRCPA, Andrew Grigg, MBBS, MD FRACP, FRCPA, Timothy P. Hughes, MD FRACP, FRCPA, MBBS
Journal: Blood
Blood (2016) 128 (22): 939.
https://doi.org/10.1182/blood.V128.22.939.939
Published: 2016
Journal Articles

Clostridium Difficile Infection in Haematology Patients Significantly Increases Length of Stay; A Case Control Study

Louise Imlay-Gillespie, BMed, Caroline Dix, MBBS, Ashley McEwan, MD, Kelly Wong, Melanie Figtree, MBBS, Christopher Arthur, MD, Luke Coyle, MBBS, FRACP, FRCPA, Keith Fay, MBChB FRACP FRCPA, Matthew Greenwood, MBBS, FRACP, FRCPA, Naomi Mackinlay, MBBS, FRACP, FRCPA, Stephen Mulligan, MBBS, PhD FRACP, FRCPA, William Stevenson, MBBS, PhD, Christopher M Ward, MBChB, PhD FRACP, FRCPA, Ian H. Kerridge, MBBS, MPhil, FRACP, FRCPA
Journal: Blood
Blood (2015) 126 (23): 2108.
https://doi.org/10.1182/blood.V126.23.2108.2108
Published: 2015
Journal Articles

Interim Positron Emission Tomography-Computed Tomography (PET-CT) Is Predictive of Post-Therapy Outcome in High Grade Transformation of Low Grade Lymphoproliferative Disorders

Louise Imlay-Gillespie, BMed, David Simon Kliman, MBBS, Kelly Wong, Christopher Arthur, MD, Luke Coyle, MBBS, FRACP, FRCPA, Keith Fay, MBChB FRACP FRCPA, Ian H. Kerridge, MBBS, MPhil, FRACP, FRCPA, Naomi Mackinlay, MBBS, FRACP, FRCPA, Stephen Mulligan, MBBS, PhD FRACP, FRCPA, William Stevenson, MBBS, PhD, Christopher M Ward, MBChB, PhD FRACP, FRCPA, Matthew Greenwood, MBBS, FRACP, FRCPA
Journal: Blood
Blood (2015) 126 (23): 5038.
https://doi.org/10.1182/blood.V126.23.5038.5038
Published: 2015
Journal Articles

A Post Hoc Landmark Analysis of Survival Probabilities in a Multinational Phase III Trial of Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Xavier Thomas, MD, Christopher Arthur, MD, Jacques Delaunay, MD, Mark M Jones, MD, Erhan Barrak, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2012) 120 (21): 3623.
https://doi.org/10.1182/blood.V120.21.3623.3623
Published: 2012
Journal Articles

Multivariate and Subgroup Analyses of a Multinational Phase III Trial of Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Jiri Mayer, M.D., PhD., Prof., Christopher Arthur, MD, Jacques Delaunay, MD, Grzegorz Mazur, MD, PhD, Xavier Thomas, MD, Agnieszka Wierzbowska, MD, PhD, Mark M Jones, MD, Erhan Berrak, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2012) 120 (21): 3618.
https://doi.org/10.1182/blood.V120.21.3618.3618
Published: 2012